Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Notes Payables (2016 - 2020)

Historic Notes Payables for Dare Bioscience (DARE) over the last 4 years, with Q4 2020 value amounting to $367285.0.

  • Dare Bioscience's Notes Payables changed N/A to $367285.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $367285.0, marking a year-over-year change of. This contributed to the annual value of $367285.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Dare Bioscience reported Notes Payables of $367285.0 as of Q4 2020.
  • Dare Bioscience's Notes Payables' 5-year high stood at $697500.0 during Q4 2016, with a 5-year trough of $367285.0 in Q2 2020.